C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in...

Boehringer Ingelheim Animal Health is a multinational animal health company, formed in January 2017 when Merial was acquired by Boehringer Ingelheim and...

Mainz-Bingen. Furthermore, Ingelheim harbours the business Boehringer Ingelheim which is active worldwide. In 2004, 36% of Ingelheim's inhabitants belonged...

[dead link‍] "Boehringer Ingelheim Financial Highlights 2023". "Boehringer Ingelheim Financial Report 2022" (PDF). "Boehringer Ingelheim Summary Report...

January, 2022. Boehringer Ingelheim researches, develops and produces pharmaceuticals. Boehringer Ingelheim was founded in Ingelheim am Rhein, Germany...

Jefferson%20City%20($280.9%20million) https://www.boehringer-ingelheim.com/us/animal-health/boehringer-ingelheim-unveils-groundbreaking-research-and-develop...

the biggest draw back of the jet nebulizer. The medical company Boehringer Ingelheim also invented a device named Respimat Soft Mist Inhaler in 1997....

chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company. The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von...

for medical use in the United States in 2000. It was developed by Boehringer Ingelheim and is available as a generic medication. In 2022, it was the 29th...

Kaiserpfalz Ingelheim. In: Archäologie in Rheinland-Pfalz. ISSN 1614-4627 François Lachenal, Robert Boehringer (Hrsg.) (1974). Ingelheim am Rhein. 774–1974...

priority review and granted the approval of Jardiance to Boehringer Ingelheim. As of May 2013, Boehringer and Lilly had submitted applications for marketing...

difficulty falling asleep or staying asleep and dry mouth. Development by Boehringer Ingelheim was halted in October 2010, following a negative evaluation by the...

university. Until 1920 he was the head of the family firm C.H. Boehringer in Ingelheim. From 1931 he took part in the establishment of Hoffmann-La Roche...

{h}}]}{{\text{output per step}}[{\ce {kg}}]}}} The process chemistry group at Boehringer Ingelheim, for example, targets a VTO of less than 1 for any given synthetic...

the project, while Boehringer Ingelheim could receive more than $800 million from development of the new drugs. Boehringer Ingelheim's oral anti-diabetic...

"Catapres 150 Tablets Catapres Ampoules" (PDF). TGA eBusiness Services. Boehringer Ingelheim Pty Limited. 28 February 2013. Archived from the original on 16 January...

Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in...

Boehringer (Böhringer) may refer to: Boehringer Ingelheim, a pharmaceutical company Boehringer Laboratories, an American medical technology company Boehringer...

inhibitor (NDRI). It was first developed in the 1960s by a team at Boehringer Ingelheim. Its activity at the dopamine transporter is six times stronger than...

deal with Boehringer Ingelheim. Sanofi would sell its Merial animal health division (valuing it at €11.4 billion), while acquiring Boehringer's consumer...

analog rather than an analog of oxyntomodulin. It is developed by Boehringer Ingelheim as a weight loss drug. Klein, Thomas; Augustin, Robert; Hennige,...

in the city, including Eli Lilly and Company, Procter & Gamble, Boehringer Ingelheim, and Nestlé. The city is the point of origin and namesake of Kobe...

and platelet derived growth factor receptor. Ofev was developed by Boehringer Ingelheim. It received U.S. Food and Drug Administration (FDA) approval for...

July 2014, a series of investigations accused the privately held Boehringer Ingelheim pharmaceutical group of withholding critical information about the...

was developed by TeGenero, tested by Parexel and manufactured by Boehringer Ingelheim. TeGenero announced the first elucidation of the molecular structure...

UK. It is marketed by various companies under licence, including Boehringer Ingelheim and CSL. Tamsulosin hydrochloride extended-release capsules are marketed...

excessive mucus. It was developed in the research laboratory of Boehringer Ingelheim in the late 1950s as an active ingredient for pharmaceutical use...

diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany). Allergy to sulfonylureas or sulfonamides Diabetes mellitus...

Chewable Tablets Cardiac drug for oral use in dogs only" (PDF). Boehringer Ingelheim Vetmedica, Inc. 2007. Archived from the original (PDF) on 6 February...

BI 685509) is a soluble guanylate cyclase activator developed by Boehringer Ingelheim for kidney disease, and cirrhosis. Cherney, David Z. I.; de Zeeuw...